Related Experiment Video
Updated: Dec 5, 2025
08:30
Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
2.3K
CD226 Throttles up CD8+ T Cell Antitumor Activity
1Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.
Immunity
|October 14, 2020
Summary
Loss of CD226 expression on CD8+ T-cells hinders their ability to fight tumors. This impairment reduces T-cell activation, weakening the body's anti-tumor immune response.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- CD8+ T-cells are crucial for anti-tumor immunity.
- T-cell activation is essential for effective anti-tumor responses.
- The role of CD226 in regulating CD8+ T-cell function requires further elucidation.
Purpose of the Study:
- To investigate the functional consequences of CD226 expression loss on CD8+ T-cells.
- To understand the impact of CD226 on T-cell receptor (TCR)-driven activation.
- To determine how impaired CD8+ T-cell activation affects anti-tumor effector responses.
Main Methods:
- Analysis of CD226 expression levels on CD8+ T-cells.
- Assessment of TCR-driven activation pathways in CD8+ T-cells.
- Evaluation of anti-tumor effector functions in models with altered CD226 expression.
Main Results:
- CD226 expression loss was observed on CD8+ T-cells.
- Impaired TCR-driven activation of CD8+ T-cells lacking CD226.
- Reduced anti-tumor effector responses associated with CD226 deficiency.
Conclusions:
- Loss of CD226 expression on CD8+ T-cells significantly impairs their anti-tumor functions.
- CD226 is critical for maintaining optimal CD8+ T-cell activation and effector responses.
- Targeting CD226 may offer therapeutic strategies to enhance anti-tumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
1.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K
01:22T Cell Activation and Clonal Selection
14.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.2K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K